• LAST PRICE
    4.8800
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (1.6667%)
  • Bid / Lots
    4.8500/ 5
  • Ask / Lots
    5.2900/ 1
  • Open / Previous Close
    4.8000 / 4.8000
  • Day Range
    Low 4.6800
    High 4.9300
  • 52 Week Range
    Low 4.4500
    High 14.7400
  • Volume
    131,959
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 4.8
TimeVolumeINMB
09:32 ET32014.82
09:33 ET20004.8957
09:35 ET2004.825
09:39 ET8004.74
09:44 ET14994.68
09:46 ET8004.695
09:50 ET9254.7195
09:55 ET6374.72
10:04 ET1004.75
10:15 ET3004.76
10:18 ET2004.75
10:22 ET19024.72
10:26 ET15094.7
10:36 ET4004.715
10:38 ET2984.725
10:42 ET9294.7
10:51 ET1004.725
10:58 ET12004.72
11:03 ET3074.73
11:07 ET21234.73
11:12 ET3954.73
11:14 ET2004.7
11:16 ET1004.69
11:18 ET1004.71
11:23 ET60004.73
11:25 ET2004.77
11:27 ET3004.77
11:34 ET1004.78
11:36 ET5684.8
11:38 ET2004.8
11:41 ET1104.825
11:43 ET3184.8224
11:54 ET4564.84
11:56 ET5004.84
12:03 ET9004.83
12:10 ET2004.825
12:12 ET9744.8
12:15 ET5004.8572
12:26 ET14004.89
12:28 ET5004.9
12:48 ET13564.885
12:50 ET33954.86
12:51 ET2004.84
12:55 ET7274.86
12:57 ET3004.88
01:04 ET2004.8774
01:09 ET51414.855
01:24 ET1004.84
01:26 ET2004.82
01:38 ET8004.81
01:45 ET3004.835
01:47 ET1334.83
02:03 ET6004.85
02:07 ET4004.8343
02:09 ET6704.82
02:20 ET18004.86
02:21 ET3004.84
02:36 ET1004.84
02:41 ET10504.85
02:54 ET4904.86
02:57 ET63004.86
03:01 ET3504.865
03:08 ET3004.88
03:10 ET2004.86
03:12 ET3004.87
03:21 ET8804.86
03:24 ET1004.86
03:28 ET1124.87
03:32 ET17204.89
03:35 ET13274.89
03:37 ET47044.885
03:42 ET2004.88
03:44 ET90004.8775
03:46 ET5004.89
03:48 ET8254.89
03:50 ET145394.9
03:51 ET8044.885
03:53 ET2004.88
03:55 ET5004.875
03:57 ET9694.87
04:00 ET78214.88
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesINMB
INmune Bio Inc
108.0M
-2.2x
---
United StatesMNPR
Monopar Therapeutics Inc
106.1M
-9.8x
---
United StatesTLSA
Tiziana Life Sciences Ltd
105.4M
-5.5x
---
United StatesCAMP
CAMP4 Therapeutics Corp
105.5M
-1.9x
---
United StatesRANI
Rani Therapeutics Holdings Inc
111.5M
-1.8x
---
United StatesCNTX
Context Therapeutics Inc
104.2M
-1.6x
---
As of 2024-11-26

Company Information

INmune Bio Inc. is a clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. It has two therapeutic platforms: a Dominant-Negative Tumor Necrosis Factor Platform (DN-TNF, XPro, XPro1595 or pegipanermin) and a Natural Killer (NK or INKmune) platform. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and a mechanistic driver of many diseases. DN-TNF product candidates are in clinical trials to determine if they can treat cancer (INB03) Mild Alzheimer's disease, Mild Cognitive Impairment and treatment-resistant depression (XPro). The NK Cell Priming Platform includes INKmune developed to prime a patient's NK cells to eliminate minimal residual disease in patients with cancer. Its product platforms utilize a precision medicine approach for the treatment of hematologic and solid tumor malignancies, and chronic inflammation.

Contact Information

Headquarters
225 Ne Mizner Blvd, Suite 640BOCA RATON, FL, United States 33432
Phone
858-964-3720
Fax
---

Executives

President, Chief Executive Officer, Director
Raymond Tesi
Chief Financial Officer
David Moss
Chief Scientific Officer
Mark Lowdell
Independent Director
Marcia Allen
Independent Director
J. Kelly Ganjei

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$108.0M
Revenue (TTM)
$42.0K
Shares Outstanding
22.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.80
EPS
$-2.18
Book Value
$2.12
P/E Ratio
-2.2x
Price/Sales (TTM)
2,570.9
Price/Cash Flow (TTM)
---
Operating Margin
-98,921.43%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.